Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Confirmation of the role of pathogenic SMAD6 variants in bicuspid aortic valve-related aortopathy.

Luyckx I, MacCarrick G, Kempers M, Meester J, Geryl C, Rombouts O, Peeters N, Claes C, Boeckx N, Sakalihasan N, Jacquinet A, Hoischen A, Vandeweyer G, Van Lent S, Saenen J, Van Craenenbroeck E, Timmermans J, Duijnhouwer A, Dietz H, Van Laer L, Loeys B, Verstraeten A.

Eur J Hum Genet. 2019 Jul;27(7):1044-1053. doi: 10.1038/s41431-019-0363-z. Epub 2019 Feb 22.

PMID:
30796334
2.

Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2.

Claes C, Van Den Daele J, Boon R, Schouteden S, Colombo A, Monasor LS, Fiers M, Ordovás L, Nami F, Bohrmann B, Tahirovic S, De Strooper B, Verfaillie CM.

Alzheimers Dement. 2019 Mar;15(3):453-464. doi: 10.1016/j.jalz.2018.09.006. Epub 2018 Nov 12.

3.

Generating tissue-resident macrophages from pluripotent stem cells: Lessons learned from microglia.

Claes C, Van den Daele J, Verfaillie CM.

Cell Immunol. 2018 Aug;330:60-67. doi: 10.1016/j.cellimm.2018.01.019. Epub 2018 Feb 2. Review.

PMID:
29433896
4.

Internal Repair of Very Large, Myopic and Recurrent Macular Holes by Creation of a Central Retinal Detachment and Silicone Oil Tamponade.

Claes CC.

Retina. 2017 Aug 28. doi: 10.1097/IAE.0000000000001767. [Epub ahead of print] No abstract available.

PMID:
28858063
5.

Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections.

Ogunjimi B, Zhang SY, Sørensen KB, Skipper KA, Carter-Timofte M, Kerner G, Luecke S, Prabakaran T, Cai Y, Meester J, Bartholomeus E, Bolar NA, Vandeweyer G, Claes C, Sillis Y, Lorenzo L, Fiorenza RA, Boucherit S, Dielman C, Heynderickx S, Elias G, Kurotova A, Auwera AV, Verstraete L, Lagae L, Verhelst H, Jansen A, Ramet J, Suls A, Smits E, Ceulemans B, Van Laer L, Plat Wilson G, Kreth J, Picard C, Von Bernuth H, Fluss J, Chabrier S, Abel L, Mortier G, Fribourg S, Mikkelsen JG, Casanova JL, Paludan SR, Mogensen TH.

J Clin Invest. 2017 Sep 1;127(9):3543-3556. doi: 10.1172/JCI92280. Epub 2017 Aug 7.

6.

Disability Policy Evaluation: Combining Logic Models and Systems Thinking.

Claes C, Ferket N, Vandevelde S, Verlet D, De Maeyer J.

Intellect Dev Disabil. 2017 Jul;55(4):247-257. doi: 10.1352/1934-9556-55.4.247.

PMID:
28753403
7.

The quality of life of older people aging in place: a literature review.

Vanleerberghe P, De Witte N, Claes C, Schalock RL, Verté D.

Qual Life Res. 2017 Nov;26(11):2899-2907. doi: 10.1007/s11136-017-1651-0. Epub 2017 Jul 13. Review.

PMID:
28707047
8.

Review of Small Gauge Vitrectomy: Progress and Innovations.

Mohamed S, Claes C, Tsang CW.

J Ophthalmol. 2017;2017:6285869. doi: 10.1155/2017/6285869. Epub 2017 May 10. Review.

9.

Evidence and Evidence-Based Practices: Are We There Yet?

Schalock RL, Gomez LE, Verdugo MA, Claes C.

Intellect Dev Disabil. 2017 Apr;55(2):112-119. doi: 10.1352/1934-9556-55.2.112.

PMID:
28375801
10.

Mutations in Splicing Factor Genes Are a Major Cause of Autosomal Dominant Retinitis Pigmentosa in Belgian Families.

Van Cauwenbergh C, Coppieters F, Roels D, De Jaegere S, Flipts H, De Zaeytijd J, Walraedt S, Claes C, Fransen E, Van Camp G, Depasse F, Casteels I, de Ravel T, Leroy BP, De Baere E.

PLoS One. 2017 Jan 11;12(1):e0170038. doi: 10.1371/journal.pone.0170038. eCollection 2017.

11.

Scale of emotional development-Short.

Sappok T, Barrett BF, Vandevelde S, Heinrich M, Poppe L, Sterkenburg P, Vonk J, Kolb J, Claes C, Bergmann T, Došen A, Morisse F.

Res Dev Disabil. 2016 Dec;59:166-175. doi: 10.1016/j.ridd.2016.08.019. Epub 2016 Sep 7.

12.

Neutral Diboron Analogues of Archetypal Aromatic Species by Spontaneous Cycloaddition.

Arrowsmith M, Böhnke J, Braunschweig H, Celik MA, Claes C, Ewing WC, Krummenacher I, Lubitz K, Schneider C.

Angew Chem Int Ed Engl. 2016 Sep 5;55(37):11271-5. doi: 10.1002/anie.201602384. Epub 2016 Jul 4.

PMID:
27374193
13.

Substance use among individuals with intellectual disabilities living independently in Flanders.

Swerts C, Vandevelde S, VanDerNagel JE, Vanderplasschen W, Claes C, De Maeyer J.

Res Dev Disabil. 2017 Apr;63:107-117. doi: 10.1016/j.ridd.2016.03.019. Epub 2016 Apr 6.

PMID:
27061044
14.

Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication.

Helsen N, Debing Y, Paeshuyse J, Dallmeier K, Boon R, Coll M, Sancho-Bru P, Claes C, Neyts J, Verfaillie CM.

J Hepatol. 2016 Mar;64(3):565-73. doi: 10.1016/j.jhep.2015.11.013. Epub 2015 Nov 25.

15.

Synthesis of cyclic diborenes with unprecedented cis-configuration.

Bissinger P, Braunschweig H, Celik MA, Claes C, Dewhurst RD, Endres S, Kelch H, Kramer T, Krummenacher I, Schneider C.

Chem Commun (Camb). 2015 Nov 14;51(88):15917-20. doi: 10.1039/c5cc07103h. Epub 2015 Sep 11.

PMID:
26360103
16.

The Portuguese version of personal outcomes scale: a psychometric validity and reliability study.

Simões C, Santos S, Claes C.

Intellect Dev Disabil. 2015 Apr;53(2):129-42. doi: 10.1352/1934-9556-53.2.129.

PMID:
25860451
17.

Does performance management affect nurses' well-being?

Decramer A, Audenaert M, Van Waeyenberg T, Claeys T, Claes C, Vandevelde S, van Loon J, Crucke S.

Eval Program Plann. 2015 Apr;49:98-105. doi: 10.1016/j.evalprogplan.2014.12.018. Epub 2014 Dec 16.

PMID:
25618817
18.

A facile and selective route to remarkably inert monocyclic NHC-stabilized boriranes.

Braunschweig H, Claes C, Damme A, Deissenberger A, Dewhurst RD, Hörl C, Kramer T.

Chem Commun (Camb). 2015 Jan 31;51(9):1627-30. doi: 10.1039/c4cc09036e.

PMID:
25503081
19.

Quality of life assessment in intellectual disabilities: the Escala Pessoal de Resultados versus the World Health Quality of Life-BREF.

Simões C, Santos S, Claes C.

Res Dev Disabil. 2015 Feb;37:171-81. doi: 10.1016/j.ridd.2014.11.010. Epub 2014 Dec 5.

PMID:
25481536
20.

An integrative approach to evidence based practices.

Claes C, van Loon J, Vandevelde S, Schalock R.

Eval Program Plann. 2015 Feb;48:132-6. doi: 10.1016/j.evalprogplan.2014.08.002. Epub 2014 Aug 21. No abstract available.

PMID:
25212690
21.

Proliferative vitreoretinopathy.

Claes C, Lafetá AP.

Dev Ophthalmol. 2014;54:188-95. doi: 10.1159/000360466. Epub 2014 Aug 26. Review.

PMID:
25196769
22.

An evidence-based approach to organization evaluation and change in human service organizations evaluation and program planning.

Schalock RL, Lee T, Verdugo M, Swart K, Claes C, van Loon J, Lee CS.

Eval Program Plann. 2014 Aug;45:110-8. doi: 10.1016/j.evalprogplan.2014.03.012. Epub 2014 Mar 31.

PMID:
24762778
23.

Broadening the phenotype of LRP2 mutations: a new mutation in LRP2 causes a predominantly ocular phenotype suggestive of Stickler syndrome.

Schrauwen I, Sommen M, Claes C, Pinner J, Flaherty M, Collins F, Van Camp G.

Clin Genet. 2014 Sep;86(3):282-6. doi: 10.1111/cge.12265. Epub 2013 Sep 23.

PMID:
23992033
24.

Quality of life in persons with intellectual disabilities and mental health problems: an explorative study.

Morisse F, Vandemaele E, Claes C, Claes L, Vandevelde S.

ScientificWorldJournal. 2013;2013:491918. doi: 10.1155/2013/491918. Epub 2013 Feb 5.

25.

A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing.

Schrauwen I, Sommen M, Corneveaux JJ, Reiman RA, Hackett NJ, Claes C, Claes K, Bitner-Glindzicz M, Coucke P, Van Camp G, Huentelman MJ.

Am J Med Genet A. 2013 Jan;161A(1):145-52. doi: 10.1002/ajmg.a.35737. Epub 2012 Dec 3.

PMID:
23208854
26.

The use of evidence-based outcomes in systems and organizations providing services and supports to persons with intellectual disability.

van Loon JH, Bonham GS, Peterson DD, Schalock RL, Claes C, Decramer AE.

Eval Program Plann. 2013 Feb;36(1):80-7. doi: 10.1016/j.evalprogplan.2012.08.002. Epub 2012 Aug 20.

PMID:
22982162
27.

A mutation in CABP2, expressed in cochlear hair cells, causes autosomal-recessive hearing impairment.

Schrauwen I, Helfmann S, Inagaki A, Predoehl F, Tabatabaiefar MA, Picher MM, Sommen M, Zazo Seco C, Oostrik J, Kremer H, Dheedene A, Claes C, Fransen E, Chaleshtori MH, Coucke P, Lee A, Moser T, Van Camp G.

Am J Hum Genet. 2012 Oct 5;91(4):636-45. doi: 10.1016/j.ajhg.2012.08.018. Epub 2012 Sep 13.

28.

COL1A1 association and otosclerosis: a meta-analysis.

Schrauwen I, Khalfallah A, Ealy M, Fransen E, Claes C, Huber A, Murillo LR, Masmoudi S, Smith RJ, Van Camp G.

Am J Med Genet A. 2012 May;158A(5):1066-70. doi: 10.1002/ajmg.a.35276. Epub 2012 Apr 9.

PMID:
22489040
29.

The influence of supports strategies, environmental factors, and client characteristics on quality of life-related personal outcomes.

Claes C, Van Hove G, Vandevelde S, van Loon J, Schalock R.

Res Dev Disabil. 2012 Jan-Feb;33(1):96-103. doi: 10.1016/j.ridd.2011.08.024. Epub 2011 Oct 4.

PMID:
22093653
30.

Family quality of life in 25 Belgian families: quantitative and qualitative exploration of social and professional support domains.

Steel R, Poppe L, Vandevelde S, Van Hove G, Claes C.

J Intellect Disabil Res. 2011 Dec;55(12):1123-35. doi: 10.1111/j.1365-2788.2011.01433.x. Epub 2011 Jun 13.

PMID:
21668801
31.

A new locus for otosclerosis, OTSC10, maps to chromosome 1q41-44.

Schrauwen I, Weegerink NJ, Fransen E, Claes C, Pennings RJ, Cremers CW, Huygen PL, Kunst HP, Van Camp G.

Clin Genet. 2011 May;79(5):495-7. doi: 10.1111/j.1399-0004.2010.01576.x. No abstract available.

PMID:
21470211
32.

Person-centered planning: analysis of research and effectiveness.

Claes C, Van Hove G, Vandevelde S, van Loon J, Schalock RL.

Intellect Dev Disabil. 2010 Dec;48(6):432-53. doi: 10.1352/1934-9556-48.6.432. Review.

PMID:
21166549
33.

Full macular translocation for choroidal neovascularization in the era of intravitreal pharmacological therapy.

Haverbeke GM, Claes C.

Retina. 2010 Nov-Dec;30(10):1739-43. doi: 10.1097/IAE.0b013e3181f57d3d. No abstract available.

PMID:
21060274
34.

[Persistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed within the German statutory health insurance].

Claes C, Mittendorf T, Graf von der Schulenburg JM.

Med Klin (Munich). 2009 Jul 15;104(7):536-42. doi: 10.1007/s00063-009-1113-8. Epub 2009 Jul 18. German.

PMID:
19618139
35.

Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.

Tatar O, Adam A, Shinoda K, Kaiserling E, Boeyden V, Claes C, Eckardt C, Eckert T, Pertile G, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

Arch Ophthalmol. 2009 Mar;127(3):275-81. doi: 10.1001/archophthalmol.2008.602.

PMID:
19273790
36.

Evaluating the inter-respondent (consumer vs. staff) reliability and construct validity (SIS vs. Vineland) of the Supports Intensity Scale on a Dutch sample.

Claes C, Van Hove G, van Loon J, Vandevelde S, Schalock RL.

J Intellect Disabil Res. 2009 Apr;53(4):329-38. doi: 10.1111/j.1365-2788.2008.01149.x. Epub 2009 Jan 15.

PMID:
19207283
37.

[Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke].

Claes C, Mittendorf T, Grond M, von der Schulenburg JM.

Med Klin (Munich). 2008 Nov 15;103(11):778-87. doi: 10.1007/s00063-008-1122-z. Epub 2009 Jan 23. German.

PMID:
19165429
38.

Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.

Tatar O, Shinoda K, Kaiserling E, Claes C, Eckardt C, Eckert T, Pertile G, Boeyden V, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group, Grisanti S.

Br J Ophthalmol. 2009 Feb;93(2):159-65. doi: 10.1136/bjo.2008.138594. Epub 2008 Oct 6.

PMID:
18838410
39.

Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.

Gong Y, Barbay JK, Buntinx M, Li J, Wauwe JV, Claes C, Lommen GV, Hornby PJ, He W.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3852-5. doi: 10.1016/j.bmcl.2008.06.059. Epub 2008 Jun 20.

PMID:
18595693
40.

Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization.

Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tübingen Bevacizumab Study Group, Adam A, Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, Scharioth GB, Grisanti S.

Arch Ophthalmol. 2008 Jun;126(6):782-90. doi: 10.1001/archopht.126.6.782.

PMID:
18541840
41.

Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects.

Claes C, Reinert RR, von der Schulenburg JM.

Eur J Health Econ. 2009 Feb;10(1):25-38. doi: 10.1007/s10198-008-0098-1. Epub 2008 Apr 1.

PMID:
18379830
42.

Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists.

Barbay JK, Gong Y, Buntinx M, Li J, Claes C, Hornby PJ, Van Lommen G, Van Wauwe J, He W.

Bioorg Med Chem Lett. 2008 Apr 15;18(8):2544-8. doi: 10.1016/j.bmcl.2008.03.049. Epub 2008 Mar 20.

PMID:
18378452
43.

Twenty-gauge transconjunctival sutureless vitrectomy trocar system.

Lafetá AP, Claes C.

Retina. 2007 Oct;27(8):1136-41. No abstract available.

PMID:
18040260
44.

Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.

Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M.

Eur J Health Econ. 2008 Feb;9(1):7-15. Epub 2007 Mar 2.

PMID:
17333089
45.

Differential influence of different hepatitis viruses on quality of life in HIV positive patients.

Tillmann HL, Kaiser T, Claes C, Schmidt RE, Manns MP, Stoll M.

Eur J Med Res. 2006 Sep 29;11(9):381-5.

PMID:
17101461
46.

Hypotony as a presentation of giant cell arteritis.

Calcagni A, Claes CA, Maheshwari M, Jacks AS.

Eye (Lond). 2007 Jan;21(1):123-4. Epub 2006 Jun 2. No abstract available.

PMID:
16751759
47.

Acute retrobulbar optic neuropathy due to rupture of an anterior communicating artery aneurysm.

Claes C, Milea D, Bodaghi B, Tran TH, LeHoang P, Blanc R.

Acta Ophthalmol Scand. 2006 Feb;84(1):145-6.

48.

Therapy of atopic eczema.

Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM.

GMS Health Technol Assess. 2006 Oct 6;2:Doc19.

49.

Therapy of moderate and severe psoriasis.

Claes C, Kulp W, Greiner W, von der Schulenburg JM, Werfel T.

GMS Health Technol Assess. 2006 Apr 26;2:Doc07.

50.

Validating the EQ-5D with time trade off for the German population.

Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM.

Eur J Health Econ. 2005 Jun;6(2):124-30.

PMID:
19787848

Supplemental Content

Support Center